Literature DB >> 20374219

Alcohol biomarkers in applied settings: recent advances and future research opportunities.

Raye Z Litten1, Ann M Bradley, Howard B Moss.   

Abstract

During the past decade, advances have been made in the identification, development, and application of alcohol biomarkers. This is important because of the unique functions that alcohol biomarkers can serve in various applied settings. To carry out these functions, biomarkers must display several features including validity, reliability, adequacy of temporal window of assessment, reasonable cost, and transportability. During the past two decades, several traditional alcohol biomarkers have been studied in multiple human studies. Meanwhile, several new, promising biomarkers, including various alcohol metabolites and alcohol biosensors, are being explored in human studies. In addition, researchers have explored using biomarkers in combination and using biomarkers in combination with self-reports, resulting in increased sensitivity with little sacrifice in specificity. Despite these advances, more research is needed to validate biomarkers, especially the new ones, in humans. Moreover, recent advances in high-throughput technologies for genomics, proteomics, and metabolomics offer unique opportunities to discover novel biomarkers, while additional research is needed to perfect newly developed alcohol sensors. Development of more accurate biomarkers will help practicing clinicians to more effectively screen and monitor individuals who suffer from alcohol use disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20374219     DOI: 10.1111/j.1530-0277.2010.01170.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  70 in total

1.  Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker.

Authors:  Michael G McDonell; Donelle N Howell; Sterling McPherson; Jennifer M Cameron; Debra Srebnik; John M Roll; Richard K Ries
Journal:  J Appl Behav Anal       Date:  2012

2.  Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders.

Authors:  Willard M Freeman; Kent E Vrana
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

3.  A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients.

Authors:  Raye Z Litten; Joanne B Fertig; Daniel E Falk; Megan L Ryan; Margaret E Mattson; Joseph F Collins; Cristin Murtaugh; Domenic Ciraulo; Alan I Green; Bankole Johnson; Helen Pettinati; Robert Swift; Maryam Afshar; Mary F Brunette; Nassima A-D Tiouririne; Kyle Kampman; Robert Stout
Journal:  Alcohol Clin Exp Res       Date:  2011-09-26       Impact factor: 3.455

4.  Levels and types of alcohol biomarkers in DUI and clinic samples for estimating workplace alcohol problems.

Authors:  Paul R Marques
Journal:  Drug Test Anal       Date:  2012-02-06       Impact factor: 3.345

Review 5.  Proteomic approaches and identification of novel therapeutic targets for alcoholism.

Authors:  Giorgio Gorini; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2013-07-31       Impact factor: 7.853

6.  Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trials.

Authors:  Daniel E Falk; Raye Z Litten; Raymond F Anton; Henry R Kranzler; Bankole A Johnson
Journal:  J Stud Alcohol Drugs       Date:  2014-03       Impact factor: 2.582

7.  A modified random walk door-to-door recruitment strategy for collecting social and biological data relating to mental health, substance use, addiction, and violence problems in a Canadian community.

Authors:  Andrea Flynn; Paul F Tremblay; Jürgen Rehm; Samantha Wells
Journal:  Int J Alcohol Drug Res       Date:  2013-06-09

8.  Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Peter I Jatlow; Ann Agro; Ran Wu; Haleh Nadim; Benjamin A Toll; Elizabeth Ralevski; Christine Nogueira; Julia Shi; James D Dziura; Ismene L Petrakis; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

Review 9.  Liver Transplantation for Alcohol-Related Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Sanjiv Saigal; Rahul Rai; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

Review 10.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.